Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Christopher B. Prentiss currently holds 338,924 shares of Adamas Pharmaceuticals Inc (ADMS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher B. Prentiss has been a net seller of ADMS stock. They have purchased $0 and sold $95.7K worth of shares.
Christopher B. Prentiss's most recent insider trade was on Apr 22, 2026, when they sold 12,267 shares at $2.74 per share.
Christopher B. Prentiss serves as Executive at Adamas Pharmaceuticals Inc (ADMS). They have executed 24 insider transactions totaling $95.7K over their tenure at the company.
Christopher B. Prentiss holds the position of Executive at Adamas Pharmaceuticals Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Christopher B. Prentiss has shown a selling trading pattern, with $0 in total purchases and $95.7K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Christopher B. Prentiss was on Jul 15, 2025, when they sold $44.4K worth of MNKD shares. This transaction involved 11,540 shares at $3.85 per share.
Christopher B. Prentiss currently owns 338,924 shares of Adamas Pharmaceuticals Inc (ADMS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Christopher B. Prentiss's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Christopher B. Prentiss has 24 Form 4 filings on record as an insider at Adamas Pharmaceuticals Inc.
Set alerts for Christopher B. Prentiss and 40,000+ other insiders.